Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-20

Clinical Trial Update: Efficacy and Safety of Influenza Vaccine During Sarcoidosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of the influenza vaccine in people with sarcoidosis; the study has completed. The results are not specified in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sarcoidosis, Influenza Vaccine | Phase 3 | Status: COMPLETED